Cover Image

Chauhan Weighted Trajectory Analysis reduces sample size requirements and expedites time-to-efficacy signals in advanced cancer clinical trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Chauhan, Utkarsh, Mackey, Daylen, Mackey, John R.
Format:	Preprint
Published:	2024
Subjects:	Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chauhan Weighted Trajectory Analysis of combined efficacy and safety outcomes for risk-benefit analysis
by: Chauhan, Utkarsh, et al.
Published: (2024)

Chauhan Weighted Trajectory Analysis of Combined Efficacy and Safety Outcomes for Risk–Benefit Analysis
by: Utkarsh Chauhan, et al.
Published: (2025)

Generalized Kernel Thinning
by: Dwivedi, Raaz, et al.
Published: (2021)

Kernel Thinning
by: Dwivedi, Raaz, et al.
Published: (2021)

Debiased Distribution Compression
by: Li, Lingxiao, et al.
Published: (2024)

Designing and evaluating advanced adaptive randomised clinical trials: a practical guide
by: Granholm, Anders, et al.
Published: (2025)

Sample size reassessment in Bayesian hybrid clinical trials
by: Ratta, Marco, et al.
Published: (2025)

It's Hard to Be Normal: The Impact of Noise on Structure-agnostic Estimation
by: Jin, Jikai, et al.
Published: (2025)

Probabilistic Inference and Learning with Stein's Method
by: Liu, Qiang, et al.
Published: (2026)

Optimal Bayesian predictive probability for delayed response in single-arm clinical trials with binary efficacy outcome
by: Yoshimoto, Takuya, et al.
Published: (2024)

Compress Then Test: Powerful Kernel Testing in Near-linear Time
by: Domingo-Enrich, Carles, et al.
Published: (2023)

Comparing restricted mean survival times in small sample clinical trials using pseudo-observations
by: Jesse, David, et al.
Published: (2024)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
by: Silva, Rebecca B., et al.
Published: (2025)

The nph2ph-transform: applications to the statistical analysis of completed clinical trials
by: Devlin, Sean M., et al.
Published: (2024)

A general Bayesian approach to design adaptive clinical trials with time-to-event outcomes
by: McGree, James M., et al.
Published: (2023)

Assessing covariate-adjusted risk differences in small-sample clinical trials
by: Schnuerch, Martin, et al.
Published: (2026)

A time-to-event three-outcome design for randomized phase II cancer trials
by: Shan, Minghua
Published: (2025)

Blinded sample size recalculation in randomized controlled trials with analysis of covariance
by: Kanata, Takumi, et al.
Published: (2025)

Q-approximation of operating characteristics of clinical trial designs
by: Gentile, Susanna, et al.
Published: (2026)

Estimand framework and intercurrent events handling for clinical trials with time-to-event outcomes
by: Fang, Yixin, et al.
Published: (2025)

Next generation clinical trials: Seamless designs and master protocols
by: Burdon, Abigail, et al.
Published: (2024)

Event-driven type design for clinical trials with recurrent events
by: Zhang, Jingwen, et al.
Published: (2026)

An adaptive design for optimizing treatment assignment in randomized clinical trials
by: Zhang, Wei, et al.
Published: (2025)

Inference of treatment effect and its regional modifiers using restricted mean survival time in multi-regional clinical trials
by: Hua, Kaiyuan, et al.
Published: (2024)

Weighting methods for truncation by death in cluster-randomized trials
by: Isenberg, Dane, et al.
Published: (2024)

Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
by: Cao, Zhi, et al.
Published: (2025)

A new method for augmenting short time series, with application to pain events in sickle cell disease
by: Utkarsh, Kumar, et al.
Published: (2026)

One-sample survival tests in the presence of non-proportional hazards in oncology clinical trials
by: Szurewsky, Chloé, et al.
Published: (2025)

The R.O.A.D. to clinical trial emulation
by: Bertsimas, Dimitris, et al.
Published: (2024)

Data-driven controlled subgroup selection in clinical trials
by: Müller, Manuel M., et al.
Published: (2025)

Family-wise error rate control in clinical trials with overlapping populations
by: Luschei, Remi, et al.
Published: (2025)

Estimation of treatment effect in clinical trials of continuous endpoints with retrieved dropouts
by: Kang, Myeongjong, et al.
Published: (2026)

Covariate-adjusted win statistics in randomized clinical trials with ordinal outcomes
by: Cao, Zhiqiang, et al.
Published: (2025)

Power and sample size calculation for multivariate longitudinal trials using the longitudinal rank sum test
by: Ghosh, Dhrubajyoti, et al.
Published: (2025)

Debiasing hazard-based, time-varying vaccine effects using vaccine-irrelevant infections: An observational extension of a pivotal Phase 3 COVID-19 vaccine efficacy trial
by: Ashby, Ethan, et al.
Published: (2025)

Blinded sample size re-estimation accounting for uncertainty in mid-trial estimation
by: Maeda, Hirotada, et al.
Published: (2026)

A decomposition of Fisher's information to inform sample size for developing fair and precise clinical prediction models -- Part 2: time-to-event outcomes
by: Riley, Richard D, et al.
Published: (2025)

Low-Rank Thinning
by: Carrell, Annabelle Michael, et al.
Published: (2025)

Mathematical programming tools for randomization purposes in small two-arm clinical trials: A case study with real data
by: Vazquez, Alan R., et al.
Published: (2024)

Adaptive clinical trials based on design-optimal e-values with automatic curtailment: An application to single-arm trials with binary data
by: Baas, Stef, et al.
Published: (2026)